About EUSA Pharma
EUSA Pharma is a company based in Hemel Hempstead (United Kingdom) founded in 2006 was acquired by Recordati in December 2021. EUSA Pharma has completed 2 acquisitions, including Cytogen and OPi Group.
- Headquarter Hemel Hempstead, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Recordati Industria Chimica E Farmaceutica S.P.A
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Jazz Pharmaceuticals
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Cytogen
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EUSA Pharma
Unlock access to complete
Funding Insights of EUSA Pharma
Detailed funding history for EUSA Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in EUSA Pharma
EUSA Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Jazz Pharmaceuticals and Recordati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Intergrated pharma focused on development, manufacturing and marketing of drugs
|
Locked | Locked | Locked | |
|
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
Locked | Locked | Locked |
Investor details for EUSA Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EUSA Pharma
EUSA Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cytogen and OPi Group.
Investment portfolio details for EUSA Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Enzymatic therapeutics for rare and severe diseases are developed.
|
Locked | Locked | 1999 | Locked | |
|
Biotechnology innovations are researched, developed, produced, and marketed.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for EUSA Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - EUSA Pharma
Detailed financials for EUSA Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eusa Pharma Comparisons
Peer comparison for EUSA Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EUSA Pharma
Detailed competitors of EUSA Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eusa Pharma
Complete news archive for EUSA Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EUSA Pharma
EUSA Pharma was founded in 2006.
EUSA Pharma is headquartered in Hemel Hempstead, United Kingdom.
EUSA Pharma was founded in 2006 and is headquartered in Hemel Hempstead, United Kingdom. Operations in the pharmaceutical sector involve research and development, manufacturing, and distribution of medications targeting both common and rare diseases. A portfolio of products spans multiple therapeutic areas. Responsible business practices are upheld throughout all activities.
EUSA Pharma has 2 investors. Key investors include Jazz Pharmaceuticals, and Recordati.